KLDO OTC
Kaleido Biosciences, Inc.
1W: +0.0%
1M: +0.0%
3M: +9900.0%
YTD: +0.0%
1Y: +0.0%
3Y: +900.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$77M
-25.3% ▼
Capital Expenditures
$1M
+71.9% ▲
5Y CAGR: +42.1%
Free Cash Flow
-$78M
-19.3% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$8M
+69.2% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$28M | -$62M | -$86M | -$82M | -$90M |
| Depreciation & Amort. | $316K | $792K | $1M | $2M | $2M |
| Stock-Based Comp. | $590K | $0 | $10M | $13M | $10M |
| Change in Working Capital | $4M | $6M | -$1M | $5M | -$263K |
| Other Non-Cash Items | $39K | $62K | $37K | $877K | $886K |
| Operating Cash Flow | -$22M | -$46M | -$76M | -$62M | -$77M |
| — Investing Activities — | |||||
| Capital Expenditures | -$1M | -$3M | -$4M | -$4M | -$1M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $438K |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $0 | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1M | -$3M | -$4M | -$4M | -$691K |
| — Financing Activities — | |||||
| Net Debt Issuance | $10M | -$105K | $7M | -$68K | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $3M | -$2M | -$528K | $3M | $112K |
| Financing Cash Flow | $50M | $99M | $75M | $40M | $70M |
| Net Change in Cash | $26M | $50M | -$5M | -$25M | -$8M |
| Cash End of Period | $29M | $78M | $74M | $48M | $41M |
| Free Cash Flow | -$24M | -$49M | -$79M | -$66M | -$78M |